BioLineRx (BLRX) Free Cash Flow (2013 - 2025)
BioLineRx (BLRX) recorded quarterly Free Cash Flow of -$3.2 million in Q4 2025, down 51.95% quarter-over-quarter from -$2.1 million in Q3 2025, and up 62.86% on a YoY basis from -$2.0 million in Q4 2024.
BioLineRx (BLRX) Free Cash Flow (2013 - 2025) Analysis & Trends
BioLineRx's Free Cash Flow history runs 13 years deep, the most recent figure standing at -$3.2 million for Q4 2025.
- In Q4 2025, Free Cash Flow rose 62.86% year-over-year to -$3.2 million; the TTM figure through Dec 2025 stood at -$8.1 million (up 81.57% YoY), while the FY2025 annual figure was -$8.0 million, up 81.63% from the prior year.
- Free Cash Flow was -$3.2 million for Q4 2025 at BioLineRx, down from -$2.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $5.0 million in Q4 2023 to a low of -$14.1 million in Q1 2024.
- Historically, Free Cash Flow has averaged -$6.2 million across 5 years, with a median of -$6.2 million in 2021.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow jumped 189.0% in 2023, then plunged 272.08% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$5.4 million in 2021, then decreased by 3.4% to -$5.6 million in 2022, then surged by 189.0% to $5.0 million in 2023, then slumped by 272.08% to -$8.6 million in 2024, then surged by 62.86% to -$3.2 million in 2025.
- The last three Free Cash Flow figures came in at -$3.2 million (Q4 2025), -$2.1 million (Q3 2025), and -$177000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | -3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.20 Mn |
| Dec 31, 2025 | -3.20 Mn |
| Sep 30, 2025 | -2.11 Mn |
| Sep 30, 2025 | -2.11 Mn |
| Jun 30, 2025 | -177,000.00 |
| Jun 30, 2025 | -177,000.00 |
| Mar 31, 2025 | -2.59 Mn |
| Mar 31, 2025 | -2.59 Mn |
| Dec 31, 2024 | -8.62 Mn |
| Dec 31, 2024 | -8.62 Mn |
| Sep 30, 2024 | -9.83 Mn |
| Sep 30, 2024 | -9.83 Mn |
| Jun 30, 2024 | -11.30 Mn |
| Jun 30, 2024 | -11.30 Mn |
| Mar 31, 2024 | -14.08 Mn |
| Mar 31, 2024 | -14.08 Mn |
| Dec 31, 2023 | 5.01 Mn |
| Dec 31, 2023 | 5.01 Mn |
| Sep 30, 2023 | -9.90 Mn |
| Sep 30, 2023 | -9.90 Mn |